Hudson Biotech

This study is testing whether a daily injection called tesamorelin can reduce fat buildup in the liver of adults with fatty liver disease. 120 participants will receive either the active drug or a placebo injection for one year, with both groups receiving lifestyle advice. The ma…

This study is testing whether a weekly injection called tirzepatide, combined with a reduced-calorie diet and more physical activity, helps people with obesity or overweight lose weight and improve related health conditions. It involves over 2,500 adults who do not have type 2 di…

This study is testing whether adding an investigational drug called Melanotan II to standard narrowband UV-B light therapy helps restore skin color in adults with stable vitiligo. Sixty participants will receive either the drug or a placebo along with light therapy for 24 weeks. …

This study is testing a new weekly injection called LY3437943 (retatrutide) to see if it helps adults with obesity or overweight lose weight. About 300 participants will receive either the drug or a placebo (dummy injection) for 48 weeks, along with diet and exercise advice. The …

This study is testing whether an investigational medication called BPC-157 can help heal moderate hamstring muscle tears more quickly. About 120 adults with recent, MRI-confirmed hamstring injuries will receive either the medication or a placebo injection for 14 days, along with …

This study is testing if a gel containing a copper-peptide mix (GHK-Cu) can help small, clean skin wounds heal faster than a placebo gel. Healthy adult volunteers will have two small, identical wounds created on their arm. Each wound will get either the test gel or the placebo ge…